Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Gozzo

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Healthcare (Basel, Switzerland)|May 27, 2023
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance DataLucia Gozzo, Antonella Nardo, Serena Brancati, et al.
Pharmacological Research|February 16, 2016
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in miceGian Marco Leggio, Maria Vincenza Catania, Daniela Puzzo, et al.
Journal of Clinical Medicine|July 27, 2024
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host DiseaseLucia Gozzo, Salvatore Leotta, Giovanni Luca Romano, et al.
Frontiers in Pharmacology|April 25, 2022
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot StudyVincenza Bonfiglio, Robert Rejdak, Katarzyna Nowomiejska, et al.
Pharmacogenomics|October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementationCsilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
Current Drug Safety|June 21, 2018
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter StudyAndrea D Pratico, Laura Longo, Silvana Mansueto, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance DatabaseArianna Scala, Teresa Angela Trunfio, Chiara Pennisi, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Healthcare (Basel, Switzerland)|May 27, 2023
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance DataLucia Gozzo, Antonella Nardo, Serena Brancati, et al.
Pharmacological Research|February 16, 2016
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in miceGian Marco Leggio, Maria Vincenza Catania, Daniela Puzzo, et al.
Journal of Clinical Medicine|July 27, 2024
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host DiseaseLucia Gozzo, Salvatore Leotta, Giovanni Luca Romano, et al.
Frontiers in Pharmacology|April 25, 2022
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot StudyVincenza Bonfiglio, Robert Rejdak, Katarzyna Nowomiejska, et al.
Pharmacogenomics|October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementationCsilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
Current Drug Safety|June 21, 2018
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter StudyAndrea D Pratico, Laura Longo, Silvana Mansueto, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance DatabaseArianna Scala, Teresa Angela Trunfio, Chiara Pennisi, et al.
Pageof 5